Dabigatran, which is one of the new generation oral anticoagulants, is a direct thrombin inhibitor and is eliminated by renal clearance. The treatment modalities to be used in dabigatran toxicity is unclear. In this article, we evaluated the efficacies of treatment modalities consisting of factor concentrate infusion, fresh frozen plasma infusion, and hemodialysis performed in three patients who were using dabigatran due to non-valvular atrial fibrillation and who developed gastrointestinal hemorrhage. One of three patients died, the other two were healed.

